IR LIBRARY News & Press Releases 08/14 IR Semiannual Report for FY 2026 (in Japanese) 08/14 IR Consolidated Financial Results for the Six Months Ended June 30, 2026 (under IFRS) 07/07 IR Notice of Completion of Exercise of the 38th Stock Acquisition Rights Issued through Third-Party Allotment (in Japanese) 07/02 IR Notice Regarding Receipt of Milestone Payment Related to Manufacturing of Emixustat for Named Patient Program more info For information on SEC filings, please visit U.S. SEC's EDGAR service. CEO Message Company Financials SEC Filings Shareholders Meeting IR News Corporate Governance Financial Events Calendar FAQs Email Alerts
